EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 60,082 shares, a growth of 468.2% from the January 15th total of 10,575 shares. Based on an average daily volume of 165,006 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 165,006 shares, the short-interest ratio is currently 0.4 days.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on ESLOY shares. UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of EssilorLuxottica in a research note on Tuesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy”.
View Our Latest Research Report on ESLOY
EssilorLuxottica Stock Performance
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
See Also
- Five stocks we like better than EssilorLuxottica
- Think You Missed Silver? You’re Wrong. Here’s Why.
- How to collect $500-$800 weekly (BlackRock’s system)
- Buy this Gold Stock Before May 2026
- Nvidia CEO Issues Bold Tesla Call
- New gold price target
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
